Anmelden

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.

Unlike nondepolarizing blockers, succinylcholine, a depolarizing blocker, has more severe adverse effects, including hyperkalemia, arrhythmia, postoperative muscle pain, increased intraocular pressure, and regurgitation of gastric content due to increased gastric pressure.

Adverse effects of directly acting agents like botulinum toxin and dantrolene include general muscle weakness and hepatotoxicity. Additionally, botulinum toxin can cause respiratory tract infections and loss of bladder control.

Lastly, centrally acting muscle relaxants, which affect the central nervous system or CNS, induce various symptoms of CNS depression. For example, tizanidine causes drowsiness, hypotension, dizziness, dry mouth, and hepatotoxicity, whereas diazepam causes anxiety, tremors, insomnia, and hallucinations. Avoiding high drug doses from being given to at-risk patients such as epileptic patients or pregnant women may help reduce the severity of the side effects.

Tags

Skeletal Muscle RelaxantsAdverse EffectsMuscle ParalysisNondepolarizing Neuromuscular BlockersHypotensionBaclofenSpastic ConditionsSuccinylcholineHyperkalemiaArrhythmiaPostoperative Muscle PainBotulinum ToxinDantroleneCNS DepressionTizanidineDiazepamHepatotoxicity

Aus Kapitel 7:

article

Now Playing

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants

305 Ansichten

article

7.1 : Neuromuskuläre Verbindung und Blockade

Skeletal Muscle Relaxants

2.6K Ansichten

article

7.2 : Klassifizierung von Skelettmuskelrelaxantien

Skeletal Muscle Relaxants

2.3K Ansichten

article

7.3 : Nichtdepolarisierende (kompetitive) neuromuskuläre Blocker: Wirkmechanismus

Skeletal Muscle Relaxants

1.2K Ansichten

article

7.4 : Nichtdepolarisierende (kompetitive) neuromuskuläre Blocker: Pharmakologische Wirkungen

Skeletal Muscle Relaxants

342 Ansichten

article

7.5 : Nichtdepolarisierende (kompetitive) neuromuskuläre Blocker: Pharmakokinetik

Skeletal Muscle Relaxants

404 Ansichten

article

7.6 : Depolarisierende Blocker: Wirkmechanismus

Skeletal Muscle Relaxants

1.0K Ansichten

article

7.7 : Depolarisierende Blocker: Pharmakokinetik

Skeletal Muscle Relaxants

277 Ansichten

article

7.8 : Direkt wirkende Muskelrelaxanzien: Dantrolen und Botulinumtoxin

Skeletal Muscle Relaxants

596 Ansichten

article

7.10 : Skelettmuskelrelaxanzien: Therapeutische Anwendungen

Skeletal Muscle Relaxants

432 Ansichten

article

7.11 : Spasmolytische Mittel: Chemische Klassifizierung

Skeletal Muscle Relaxants

827 Ansichten

article

7.12 : Peripher und zentral wirkende Muskelrelaxanzien: Ein Vergleich

Skeletal Muscle Relaxants

2.9K Ansichten

article

7.13 : Zentral wirkende Muskelrelaxanzien: Therapeutische Anwendungen

Skeletal Muscle Relaxants

557 Ansichten

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten